Intracoronary Administration of Abciximab Acutely Increases Flow Through Culprit Vessels of Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
- 11 November 2003
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation
- Vol. 108 (19)
- https://doi.org/10.1161/01.cir.0000099921.71299.d9
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Reduction of Major Adverse Cardiac Events With Intracoronary Compared With Intravenous Bolus Application of Abciximab in Patients With Acute Myocardial Infarction or Unstable Angina Undergoing Coronary AngioplastyCirculation, 2003
- Abciximab, Eptifibatide, and Tirofiban Exhibit Dose-dependent Potencies to Dissolve Platelet AggregatesJournal of Cardiovascular Pharmacology, 2003
- An Additional Mechanism of Action of Abciximab: Dispersal of Newly Formed Platelet AggregatesThrombosis and Haemostasis, 2002